Non-Small Cell Lung Cancer Diagnosis Diagnosis Methods Terminal Illness Liquid Biopsy Complications mRNA Vaccine Clinical Trials Obesity and Cancer Treatment Immunotherapy in Lung Cancer Pulmonary Pleomorphic Carcinoma Self-Referral Programs Patient Care Early Detection Treatment Options RAS Mutations Breast Cancer Symptoms Causes Risk Factors Statistics Small Cell Lung Cancer KRAS G12C-mutated NSCLC Hospice Care Nonsmokers and Lung Cancer Immunotherapy Experimental Vaccines mRNA Vaccines
Subject to health ministry sign-off, the screening program is slated to launch in April 2026 to prevent up to 1,000 lung cancer deaths annually.